Merus N.V
NASDAQ:MRUS
| Market Cap (Intraday) | 2.30B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $41.56 |
| 50-Day MA | $44.88 |
| 200-Day MA | $30.30 |
Merus N.V Stock, NASDAQ:MRUS
Uppsalalaan 17, 3rd-4th Floor, Utrecht, Utrecht 3584 CM
Netherlands
Phone: +31.30.253.88.00
Number of Employees:
Description
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.